Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Background and Environment Affect Phenotype02:27

Background and Environment Affect Phenotype

7.7K
Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
7.7K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

966
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
966
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

563
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
563

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A microRNA atlas of the human prefrontal cortex across the adult lifespan.

bioRxiv : the preprint server for biology·2026
Same author

A Translational Platform for Polyimide Neural Interfaces: Polyimide Synthesis and in Vivo Evaluation in Epileptic Mice.

IEEE access : practical innovations, open solutions·2026
Same author

TREM2 and APOE are dispensable for microglial clearance of dying neurons revealed by <i>in vivo</i> imaging.

iScience·2026
Same author

Aging-related Transcriptomic Changes with Spatial Resolution in the Human Prefrontal Cortex.

bioRxiv : the preprint server for biology·2026
Same author

Age-dependent transcriptomic effects of morphine in the frontal cortex of female mice.

Neuropharmacology·2025
Same author

Acute activation of Gq-signaling in islet macrophages inhibits β-cell insulin secretion through AMPK-sphingolipid axis.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Feb 7, 2026

Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease
05:53

Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease

Published on: July 18, 2019

17.7K

Lafora disease: from genotype to phenotype.

Rashmi Parihar1, Anupama Rai, Subramaniam Ganesh

  • 1Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208 016, India. sganesh@iitk.ac.in.

Journal of Genetics
|July 21, 2018
PubMed
Summary

Lafora disease (LD) is a fatal neurodegenerative disorder caused by mutations in EPM2A or NHLRC1 genes. Mouse models reveal Lafora body formation and cellular pathway disruptions, aiding therapeutic research.

More Related Videos

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

17.4K
Genotyping of Sea Anemone during Early Development
07:04

Genotyping of Sea Anemone during Early Development

Published on: May 13, 2019

6.1K

Related Experiment Videos

Last Updated: Feb 7, 2026

Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease
05:53

Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease

Published on: July 18, 2019

17.7K
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

17.4K
Genotyping of Sea Anemone during Early Development
07:04

Genotyping of Sea Anemone during Early Development

Published on: May 13, 2019

6.1K

Area of Science:

  • Neurodegenerative diseases
  • Genetics
  • Biochemistry

Background:

  • Lafora disease (LD) is a severe, autosomal recessive neurodegenerative disorder.
  • Characterized by epilepsy and cognitive decline, typically starting in adolescence and leading to death within a decade.
  • Caused by mutations in EPM2A (laforin) or NHLRC1 (malin), affecting glycogen metabolism.

Purpose of the Study:

  • To comprehensively review the genetic basis of Lafora disease.
  • To elucidate the functions of laforin and malin proteins.
  • To discuss insights from animal models into disease mechanisms and therapeutic strategies.

Main Methods:

  • Review of genetic defects in human Lafora disease.
  • Analysis of laforin and malin protein functions.
  • Examination of findings from Epm2a and Nhlrc1 knockout mouse models.

Main Results:

  • Loss-of-function mutations in EPM2A or NHLRC1 cause Lafora disease.
  • Lafora bodies (abnormal glycogen inclusions) are a hallmark pathology.
  • Animal models exhibit Lafora bodies, proteasome/autophagy dysfunction, and inflammation.

Conclusions:

  • Defects in laforin or malin lead to a similar severe phenotype.
  • Animal models are crucial for understanding Lafora disease pathomechanisms.
  • Progress in therapeutic strategies is being made in preclinical models.